← Back to All Stocks

Citius Pharmaceuticals, Inc. (CTXR) Analysis

Generated on: 2025-07-31 13:19:17 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.
⚠️ VERY LOW FLOAT STOCK - 9,595,634 shares

Analysis Values

Current Price
$1.65
Predicted Price
$1.74
Expected Return
4.53%
Confidence Score
0.83
RSI (14)
39.74
MACD
0.04
Volume
464,100
Float Shares
9,595,634
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
250

CTXR

Citius Pharmaceuticals, Inc.
4.53%
Price: $1.65
Confidence: 0.83
News
Low Float
Last updated: 2025-07-31 13:19:17

Technical Analysis

RSI: 39.74
MACD: 0.04
Technical Analysis Graph

Risk Analysis

Volatility
136.15%
Max Drawdown
-97.33%
Beta
1.0
Risk Score
100

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
Citius Pharmaceuticals Prepares for Q2 2025 Commercial Launch of FDA-Approved Cancer Drug LYMPHIR
Insider Monkey - 2025-07-06 08:01
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) is one of the best hot stocks to buy according to Wall Street analysts. In the middle of June, Citius Oncology, which is an oncology-focused subsidiary of Citius Pharmaceuticals, announced that it is nearing completion of preparations for the commercial launch of LYMPHIR. LYMPHIR is an FDA-approved immunotherapy for the treatment […]

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.